Substance Information
In ZINC since |
Heavy atoms |
Benign functionality |
November 7th, 2005 |
46 |
No
|
Other Names:
(10R,11R,15R,16S)-16-{[(4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(thiophen-2-yl)-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one
(5R-(5alpha,5abeta,8aalpha,9beta(R*)))-5,8,8a,9-Tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4-6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one; 4'-Demethyl 1-O-(4,6-O,O-(2-thenylidene)-beta-D-gluc
23362-13-2
29767-20-2
29767-20-2; C11153; Teniposide; VM-26
29767-20-2; D02698; Teniposide (USAN/INN); Vumon (TN)
299-36-5
31514-29-1
35317-44-3
4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin-beta-D-thenylidene glucoside; HSDB 6546; NSC 122819; NSC-122819
4'-Demethylepipodophyllotoxin thenylidene glucoside
4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside
4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin
4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside
55256-09-2
AC-759
AC1L1K9H
AC1L1S3X
AC1L32H7
AC1L5IF3
AC1L9QDK
AC1NR4S8
AC1O8FOE
Ambap29767-20-2
AR-1A6252
AR-1A6526
BAN
BRD-A35588707-001-02-2
BSPBio_003436
C11153
C32H32O13S
CCRIS 2058
CHEBI:9917
CHEMBL278534
CID107642
CID275784
CID34698
CID452548
CID5284623
CID5396
CID6708778
D02698
DAP000651
DB00444
Demethyl Epipodophyllotoxin Thenylidine Glucoside
DivK1c_006888
EINECS 249-831-2
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside)
Epipodophyllotoxin-beta-D-thenylidene-glucoside, 4'-demethyl-
FDA
FT-0080118
HMS1922B15
HMS2093O15
HSDB 6546
I06-2040
INN
KBio1_001832
KBio2_002029
KBio2_004597
KBio2_007165
KBio3_002939
KBioGR_001050
KBioSS_002029
KST-1A3576
KST-1A5976
LS-63999
MFCD00866516
MLS000766234
MolPort-003-666-525
MolPort-005-940-276
MolPort-006-822-656
NCI60_000540
Neuro_000056
NSC 122819
NSC 12819
NSC-122819
NSC122819
PTG
S1787_Selleck
SMR000528847
SPBio_001773
SpecPlus_000792
SPECTRUM1504094
Spectrum2_001647
Spectrum3_001898
Spectrum4_000585
Spectrum5_001111
Spectrum_001549
Teniposide (BAN
Teniposide (FDA
Teniposide (USAN/INN)
Teniposide [USAN:BAN:INN]
teniposide; teniposido; teniposidum
Teniposido
Teniposido [INN-Spanish]
Teniposido [INN-Spanish];Teniposidum [INN-Latin]
Teniposidum
Teniposidum [INN-Latin]
UNII-957E6438QA
USAN)
Vee M-26
Veham-Sandoz
Vehem
VM 26
VM-26
Vumon
Vumon (TN)
Vumon, VM-26, Vehem, NSC 122819, Teniposide
Download:
MOL2
SDF
SMILES
Flexibase
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.81 |
-8.39 |
-20.43 |
3 |
13 |
0 |
160 |
656.662 |
6 |
↓
|
Vendor Notes
Note Type |
Comments |
Provided By |
ALOGPS_SOLUBILITY |
5.98e-02 g/l |
DrugBank-approved |
Indications |
acute lymphocytic leukemia |
KeyOrganics Bioactives |
PUBCHEM_PATENT_ID |
EP0007597A1; EP0110955A1; EP0110955B1; EP0120907A1; EP0185740A1; EP0226202A2; EP0226202B1; EP0261174A1; EP0270340A2; EP0270340B1; EP0289030A2; EP0291957A2; EP0292710A2; EP0292710B1; EP0297594A2; EP0302473A2; EP0302473B1; EP0304086A2; EP0304086B1; EP030597 |
IBM Patent Data |
No pre-computed analogs available. Try a structural similarity search.